Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 10-K Report Annual Report
  7. 8-K Event Results of operations
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 8-K Event Results of operations · Other events
  15. 8-K Event Other events
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Other events
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 24 of 37 · 725 filings